106 related articles for article (PubMed ID: 25031044)
1. Effectiveness of Chinese prescription Kangen-karyu for dyslipi-demia, using 3T3-L1 adipocytes and type 2 diabetic mice.
Hum Park C; Young Rhyu D; Sook Noh J; Min Park C; Yokozawa T
Drug Discov Ther; 2014 Jun; 8(3):121-31. PubMed ID: 25031044
[TBL] [Abstract][Full Text] [Related]
2. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
Yamabe N; Kim HY; Kang KS; Zhao Q; Matsumoto K; Yokozawa T
J Ethnopharmacol; 2010 Jun; 129(3):299-305. PubMed ID: 20363309
[TBL] [Abstract][Full Text] [Related]
3. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.
Okamoto T; Park CH; Noh JS; Toriizuka K; Sei Y; Park JC; Yokozawa T
J Pharm Pharmacol; 2011 Jul; 63(7):952-9. PubMed ID: 21635261
[TBL] [Abstract][Full Text] [Related]
4. Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
Park CH; Yamabe N; Okamoto T; Toriizuka K; Yokozawa T
Biol Pharm Bull; 2011; 34(3):383-8. PubMed ID: 21372389
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats.
Cho EJ; Yokozawa T; Okamoto T
J Pharm Pharmacol; 2007 May; 59(5):687-94. PubMed ID: 17524234
[TBL] [Abstract][Full Text] [Related]
6. Scientific evidence for therapeutic effects of Chinese prescription Kangen-karyu from pre-clinical animal experiments.
Yokozawa T; Park CH; Matsumoto K
Drug Discov Ther; 2017 Mar; 11(1):6-14. PubMed ID: 28123156
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic db/db Mice.
Park CH; Noh JS; Okamoto T; Park JC; Yokozawa T
Evid Based Complement Alternat Med; 2012; 2012():143489. PubMed ID: 22969821
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
Kim HY; Okamoto T; Yokozawa T
J Ethnopharmacol; 2009 Jul; 124(2):263-9. PubMed ID: 19397970
[TBL] [Abstract][Full Text] [Related]
9. Antioxidative effects related to the potential anti-aging properties of the Chinese prescription Kangen-karyu and Carthami Flos in senescence-accelerated mice.
Satoh A; Yokozawa T; Cho EJ; Okamoto T; Sei Y
Arch Gerontol Geriatr; 2004; 39(1):69-82. PubMed ID: 15158582
[TBL] [Abstract][Full Text] [Related]
10. The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model.
Yokozawa T; Kim HJ; Yamabe N; Okamoto T; Cho EJ
J Pharm Pharmacol; 2007 Sep; 59(9):1271-8. PubMed ID: 17883899
[TBL] [Abstract][Full Text] [Related]
11. The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats.
Yokozawa T; Cho EJ; Sasaki S; Satoh A; Okamoto T; Sei Y
Biol Pharm Bull; 2006 Apr; 29(4):760-5. PubMed ID: 16595914
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Chinese prescription Kangen-karyu and its crude drug Tanjin on ageing process in rats.
Yokozawa T; Cho EJ; Okamoto T; Sei Y
J Pharm Pharmacol; 2006 Dec; 58(12):1591-9. PubMed ID: 17331322
[TBL] [Abstract][Full Text] [Related]
13. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.
Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW
Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872
[TBL] [Abstract][Full Text] [Related]
14. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
[TBL] [Abstract][Full Text] [Related]
15. Chinese prescription Kangen-karyu and Salviae Miltiorrhizae Radix improve age-related oxidative stress and inflammatory response through the PI3K/Akt or MAPK pathways.
Park CH; Kim DH; Park MH; Kim MK; Kim ND; Kim CM; Tanaka T; Yokozawa T; Chung HY; Moon HR
Am J Chin Med; 2014; 42(4):987-1005. PubMed ID: 25004887
[TBL] [Abstract][Full Text] [Related]
16. Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes.
Noh JS; Park CH; Kim HY; Zhao Q; Yamabe N; Matsumoto K; Yokozawa T
J Pharm Pharmacol; 2011 Jan; 63(1):111-9. PubMed ID: 21155823
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Chinese prescription Kangen-karyu for patient with metabolic syndrome.
Kitazawa T; Park CH; Hiratani K; Choi JS; Yokozawa T
Drug Discov Ther; 2020 Mar; 14(1):54-57. PubMed ID: 32115440
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells.
Yokozawa T; Kim YA; Kim HY; Okamoto T; Sei Y
J Ethnopharmacol; 2007 Jan; 109(1):113-20. PubMed ID: 16949779
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms underlying the anti-aging activity of the Chinese prescription Kangen-karyu in hydrogen peroxide-induced human fibroblasts.
Satoh A; Yokozawa T; Kim YA; Cho EJ; Okamoto T; Sei Y
J Pharm Pharmacol; 2005 Oct; 57(10):1335-43. PubMed ID: 16259763
[TBL] [Abstract][Full Text] [Related]
20. Korean Chungtaejeon tea extract attenuates body weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes.
Sharma BR; Kim DW; Rhyu DY
J Integr Med; 2017 Jan; 15(1):56-63. PubMed ID: 28088260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
